AI assistant
CONTROL BIONICS LIMITED — Share Issue/Capital Change 2021
Feb 22, 2021
64611_rns_2021-02-22_be09d4b5-5095-4e8a-8777-dae85c968aac.pdf
Share Issue/Capital Change
Open in viewerOpens in your device viewer
==> picture [102 x 36] intentionally omitted <==
23 February 2021
ASX ANNOUNCEMENT
Release of shares from escrow
Control Bionics Ltd (ASX: CBL) announces that in accordance with listing rule 3.10A, a total of 14,956,528 ordinary fully paid shares will be released from voluntary escrow on 5 March 2021.
This announcement was authorised by the CEO, Rob Wong.
Investors
Rob Wong - CEO [email protected]
Media
M&C Partners Melissa Hamilton [email protected]
For further information visit the website: https://www.controlbionics.com/
About Control Bionics:
Control Bionics is a technology company which enables a disabled person to use their own neuroelectric signals, from their brain to a muscle, to control communication and movement through smartphones, tablets, computers and robotics, even when that muscle is not fully functional. The Company’s wireless wearable device, ‘ NeuroNode ’, is a world leader in electromyography (EMG), capturing and processing those neuroelectric signals into electronic commands to do everything they would normally do with a keyboard, mouse, joystick or touchscreen. The technology also enables a person to use their eyes to replace a mouse in controlling a cursor on a screen simply by looking where they want the cursor to move; and then to select anything under the cursor, using NeuroNode; providing fast, intuitive communication and control through text, text-to-speech, emails, phone-messaging, web surfing and robotics.
Control Bionics Limited Registered Office: Suite G.03, 171 Union Road, Surrey Hills, VIC, 3127 T: +61 3 9897 3576 W: www.controlbionics.com
ABN: 45 115 465 462